Logo image of CHX

CHAMPIONX CORP (CHX) Stock Fundamental Analysis

NASDAQ:CHX - Nasdaq - US15872M1045 - Common Stock - Currency: USD

24.48  -0.02 (-0.08%)

After market: 24.48 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CHX. CHX was compared to 62 industry peers in the Energy Equipment & Services industry. CHX scores excellent on profitability, but there are some minor concerns on its financial health. CHX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CHX had positive earnings in the past year.
In the past year CHX had a positive cash flow from operations.
Of the past 5 years CHX 4 years were profitable.
Each year in the past 5 years CHX had a positive operating cash flow.
CHX Yearly Net Income VS EBIT VS OCF VS FCFCHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

With a decent Return On Assets value of 8.37%, CHX is doing good in the industry, outperforming 79.03% of the companies in the same industry.
With a decent Return On Equity value of 15.29%, CHX is doing good in the industry, outperforming 77.42% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 13.87%, CHX belongs to the top of the industry, outperforming 87.10% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHX is above the industry average of 8.69%.
The last Return On Invested Capital (13.87%) for CHX is above the 3 year average (13.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.37%
ROE 15.29%
ROIC 13.87%
ROA(3y)7.83%
ROA(5y)1.06%
ROE(3y)15.08%
ROE(5y)1.18%
ROIC(3y)13.65%
ROIC(5y)9.48%
CHX Yearly ROA, ROE, ROICCHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

With a decent Profit Margin value of 8.20%, CHX is doing good in the industry, outperforming 64.52% of the companies in the same industry.
In the last couple of years the Profit Margin of CHX has grown nicely.
Looking at the Operating Margin, with a value of 14.13%, CHX is in the better half of the industry, outperforming 70.97% of the companies in the same industry.
CHX's Operating Margin has improved in the last couple of years.
CHX has a Gross Margin of 33.16%. This is in the better half of the industry: CHX outperforms 62.90% of its industry peers.
CHX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.13%
PM (TTM) 8.2%
GM 33.16%
OM growth 3Y32.96%
OM growth 5Y8.66%
PM growth 3Y33.74%
PM growth 5Y13.82%
GM growth 3Y10.44%
GM growth 5Y-0.48%
CHX Yearly Profit, Operating, Gross MarginsCHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHX is creating some value.
The number of shares outstanding for CHX has been reduced compared to 1 year ago.
CHX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CHX has been reduced compared to a year ago.
CHX Yearly Shares OutstandingCHX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CHX Yearly Total Debt VS Total AssetsCHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CHX has a debt to FCF ratio of 1.74. This is a very positive value and a sign of high solvency as it would only need 1.74 years to pay back of all of its debts.
CHX's Debt to FCF ratio of 1.74 is amongst the best of the industry. CHX outperforms 80.65% of its industry peers.
CHX has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
CHX has a Debt to Equity ratio of 0.31. This is comparable to the rest of the industry: CHX outperforms 59.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.74
Altman-Z N/A
ROIC/WACC1.5
WACC9.27%
CHX Yearly LT Debt VS Equity VS FCFCHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 2.25 indicates that CHX has no problem at all paying its short term obligations.
CHX has a better Current ratio (2.25) than 69.35% of its industry peers.
A Quick Ratio of 1.62 indicates that CHX should not have too much problems paying its short term obligations.
CHX has a Quick ratio of 1.62. This is in the better half of the industry: CHX outperforms 61.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.62
CHX Yearly Current Assets VS Current LiabilitesCHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CHX have decreased by -1.63% in the last year.
CHX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.09% yearly.
CHX shows a decrease in Revenue. In the last year, the revenue decreased by -4.17%.
CHX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.29% yearly.
EPS 1Y (TTM)-1.63%
EPS 3Y44.49%
EPS 5Y11.09%
EPS Q2Q%0%
Revenue 1Y (TTM)-4.17%
Revenue growth 3Y5.73%
Revenue growth 5Y26.29%
Sales Q2Q%-6.25%

3.2 Future

Based on estimates for the next years, CHX will show a small growth in Earnings Per Share. The EPS will grow by 6.80% on average per year.
Based on estimates for the next years, CHX will show a small growth in Revenue. The Revenue will grow by 2.82% on average per year.
EPS Next Y13.71%
EPS Next 2Y9.04%
EPS Next 3Y7.38%
EPS Next 5Y6.8%
Revenue Next Year-2.65%
Revenue Next 2Y0.45%
Revenue Next 3Y0.28%
Revenue Next 5Y2.82%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHX Yearly Revenue VS EstimatesCHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
CHX Yearly EPS VS EstimatesCHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.52, the valuation of CHX can be described as correct.
CHX's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 25.82. CHX is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 11.37, the valuation of CHX can be described as reasonable.
CHX's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.76. CHX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.52
Fwd PE 11.37
CHX Price Earnings VS Forward Price EarningsCHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHX is valued a bit more expensive than the industry average as 62.90% of the companies are valued more cheaply.
CHX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 13.69
EV/EBITDA 6.33
CHX Per share dataCHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CHX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CHX has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.99
PEG (5Y)1.22
EPS Next 2Y9.04%
EPS Next 3Y7.38%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.46%, CHX has a reasonable but not impressive dividend return.
CHX's Dividend Yield is a higher than the industry average which is at 4.01.
Compared to the average S&P500 Dividend Yield of 2.36, CHX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.46%

5.2 History

The dividend of CHX decreases each year by -47.78%.
CHX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)-47.78%
Div Incr Years2
Div Non Decr Years2
CHX Yearly Dividends per shareCHX Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

24.70% of the earnings are spent on dividend by CHX. This is a low number and sustainable payout ratio.
DP24.7%
EPS Next 2Y9.04%
EPS Next 3Y7.38%
CHX Yearly Income VS Free CF VS DividendCHX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M
CHX Dividend Payout.CHX Dividend Payout, showing the Payout Ratio.CHX Dividend Payout.PayoutRetained Earnings

CHAMPIONX CORP

NASDAQ:CHX (5/23/2025, 4:30:00 PM)

After market: 24.48 0 (0%)

24.48

-0.02 (-0.08%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-17 2025-07-17/amc
Inst Owners93.61%
Inst Owner Change4.59%
Ins Owners1.36%
Ins Owner Change18.7%
Market Cap4.69B
Analysts86.67
Price Target42.23 (72.51%)
Short Float %3.9%
Short Ratio1.4
Dividend
Industry RankSector Rank
Dividend Yield 1.46%
Yearly Dividend0.37
Dividend Growth(5Y)-47.78%
DP24.7%
Div Incr Years2
Div Non Decr Years2
Ex-Date07-03 2025-07-03 (0.095)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)0.36%
Max EPS beat(2)14.53%
EPS beat(4)2
Avg EPS beat(4)-2.36%
Min EPS beat(4)-19.69%
Max EPS beat(4)14.53%
EPS beat(8)4
Avg EPS beat(8)0.56%
EPS beat(12)8
Avg EPS beat(12)1.75%
EPS beat(16)11
Avg EPS beat(16)1.71%
Revenue beat(2)0
Avg Revenue beat(2)-2.81%
Min Revenue beat(2)-4.47%
Max Revenue beat(2)-1.16%
Revenue beat(4)0
Avg Revenue beat(4)-4.29%
Min Revenue beat(4)-7.8%
Max Revenue beat(4)-1.16%
Revenue beat(8)0
Avg Revenue beat(8)-3.77%
Revenue beat(12)2
Avg Revenue beat(12)-2.06%
Revenue beat(16)5
Avg Revenue beat(16)-1.12%
PT rev (1m)-3.72%
PT rev (3m)-4.67%
EPS NQ rev (1m)-0.81%
EPS NQ rev (3m)0.78%
EPS NY rev (1m)-4.28%
EPS NY rev (3m)-1.39%
Revenue NQ rev (1m)-2.44%
Revenue NQ rev (3m)-2.83%
Revenue NY rev (1m)-4.81%
Revenue NY rev (3m)-6.35%
Valuation
Industry RankSector Rank
PE 13.52
Fwd PE 11.37
P/S 1.31
P/FCF 13.69
P/OCF 9.7
P/B 2.45
P/tB 4.47
EV/EBITDA 6.33
EPS(TTM)1.81
EY7.39%
EPS(NY)2.15
Fwd EY8.79%
FCF(TTM)1.79
FCFY7.3%
OCF(TTM)2.52
OCFY10.31%
SpS18.68
BVpS10.01
TBVpS5.48
PEG (NY)0.99
PEG (5Y)1.22
Profitability
Industry RankSector Rank
ROA 8.37%
ROE 15.29%
ROCE 18.61%
ROIC 13.87%
ROICexc 17.2%
ROICexgc 28.5%
OM 14.13%
PM (TTM) 8.2%
GM 33.16%
FCFM 9.57%
ROA(3y)7.83%
ROA(5y)1.06%
ROE(3y)15.08%
ROE(5y)1.18%
ROIC(3y)13.65%
ROIC(5y)9.48%
ROICexc(3y)15.86%
ROICexc(5y)10.93%
ROICexgc(3y)28.04%
ROICexgc(5y)19.36%
ROCE(3y)18.31%
ROCE(5y)12.72%
ROICexcg growth 3Y47.18%
ROICexcg growth 5Y16.9%
ROICexc growth 3Y46.83%
ROICexc growth 5Y30.42%
OM growth 3Y32.96%
OM growth 5Y8.66%
PM growth 3Y33.74%
PM growth 5Y13.82%
GM growth 3Y10.44%
GM growth 5Y-0.48%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.74
Debt/EBITDA 0.79
Cap/Depr 57.1%
Cap/Sales 3.93%
Interest Coverage 250
Cash Conversion 64.26%
Profit Quality 116.78%
Current Ratio 2.25
Quick Ratio 1.62
Altman-Z N/A
F-Score6
WACC9.27%
ROIC/WACC1.5
Cap/Depr(3y)53.43%
Cap/Depr(5y)43.4%
Cap/Sales(3y)3.46%
Cap/Sales(5y)3.1%
Profit Quality(3y)155.68%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.63%
EPS 3Y44.49%
EPS 5Y11.09%
EPS Q2Q%0%
EPS Next Y13.71%
EPS Next 2Y9.04%
EPS Next 3Y7.38%
EPS Next 5Y6.8%
Revenue 1Y (TTM)-4.17%
Revenue growth 3Y5.73%
Revenue growth 5Y26.29%
Sales Q2Q%-6.25%
Revenue Next Year-2.65%
Revenue Next 2Y0.45%
Revenue Next 3Y0.28%
Revenue Next 5Y2.82%
EBIT growth 1Y-1.81%
EBIT growth 3Y40.57%
EBIT growth 5Y37.22%
EBIT Next Year58.64%
EBIT Next 3Y21.67%
EBIT Next 5Y9.34%
FCF growth 1Y-23.96%
FCF growth 3Y22.54%
FCF growth 5Y31.03%
OCF growth 1Y-12.01%
OCF growth 3Y21.57%
OCF growth 5Y30.48%